Innovative drug infusion technology for laboratory animals.


  • ニュースIMS-310R iPRECIOマネジメントシステム期間限定キャンペーンのご案内
    3月31日まで 期間限定 特別価格にて販売中です。

  • 2021/02/17

  • ニュースIMS-200 iPRECIOマネジメントシステムのアップグレードのご案内
    IMS-200マネジメントシステムソフトウェア アップグレード用CDの無料配布を開始致しました。

    ※シリアル番号 20xxxx のポンプご利用のお客様はアップグレードが必要となります。

  • 2020/09/29

  • ニュースSMP-310R iPRECIO マイクロインフュージョンポンプ

  • 2020/09/29

  • ニュース101 discreet infusion flow-rates and programmable infusions protocols (simple and complex)? Start all pumps simultaneously after recovery. Program starts and stops. Wondering how you would program this? Contact Primetech and ask us to have access to iPRECIO IMS-310R Group Profile or infusion < click here >. iPRECIO minipumps are the only programmable refillable and implantable drug delivery devices on the market.

  • 2020/05/14

  • イベントLooking to be inspired? “Dreams and Perseverance” Prof Robert Langer - Co-organizer of US-JAPAN SYMPOSIUM ON DRUG DELIVERY SYSTEMS. You can also join him for a chat, COVID-19: A chat with Bob Langer on vaccines, nanotech & the future of healthcare. Details are here, - #nanotech #the_future_of_healthcare hashtag #drugdelivery #drugdiscovery

  • 2020/04/20

  • ニュースiPRECIO® for Mouse or larger – New Publication “Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism” Excerpt - By using an intracerebral infusion system equipped with implantable, programmable, and refillable pumps, we show herein that continuous intrastriatal administration of memantine (MMT), which is a non-competitive N-methyl-D-aspartate receptor antagonist, attenuates levodopa-induced dyskinesias and parkinsonian signs in 6-hydroxydopamine-lesioned hemiparkinsonian mice that received daily levodopa treatment.

  • 2020/01/24

Page top